| Content Provider |
World Health Organization (WHO)-Global Index Medicus |
| Author |
Zhou, Weibin Chen, Min Yuan, Jingyun Sun, Yan |
| Description |
Author Affiliation: Zhou W ( Department of Endocrinology, The First Affiliated Hospital, College of Medicine, Zhejiang University, No. 79, Qingchun Road, Hangzhou, Zhejiang 310003, PR China.); Chen M ( Department of Endocrinology, The First Affiliated Hospital, College of Medicine, Zhejiang University, No. 79, Qingchun Road, Hangzhou, Zhejiang 310003, PR China. Electronic address: pdsucs@126.com.); Yuan J ( Department of Endocrinology, The First Affiliated Hospital, College of Medicine, Zhejiang University, No. 79, Qingchun Road, Hangzhou, Zhejiang 310003, PR China.); Sun Y ( Department of Endocrinology, The First Affiliated Hospital, College of Medicine, Zhejiang University, No. 79, Qingchun Road, Hangzhou, Zhejiang 310003, PR China.) |
| Abstract |
AIMS: The primary objective was to evaluate the impact of the smart phone-based diabetes management application, Welltang, on glycated hemoglobin (HbA1c). The second objective was to measure whether Welltang improves blood glucose, low-density lipoprotein cholesterol, weight, blood pressure, hypoglycemic events, satisfaction of patients to use Welltang, diabetes knowledge of patients, and self-care behaviors. METHODS: One hundred evenly randomized subjects with diabetes, aged 18-74years, were recruited from the outpatient Department of Endocrinology for a 3-month study. The Welltang intervention group received training for the use of Welltang, while the control group received their usual standard of care. HbA1c, blood glucose, low-density lipoprotein cholesterol, weight, blood pressure, hypoglycemic events, satisfaction of patients to use Welltang, diabetes knowledge of patients, and self-care behaviors were measured. Patient data were analyzed using independent t test and paired sample test using SPSS version 12. RESULTS: The average decrease in HbA1c was 1.95% (21mmol/mol) in the intervention group and 0.79% (8mmol/mol) in the control group (P<0.001). Measures of self-monitored blood glucose, diabetes knowledge, and self-care behaviors improved in patients in the intervention group. Eighty four percent of patients in the intervention group were satisfied with the use of Welltang. Differences in hypoglycemic events, low-density lipoprotein cholesterol, weight, and blood pressure were not statistically significant. CONCLUSION: Diabetes patients using the Welltang application achieved statistically significant improvements in HbA1c, blood glucose, satisfaction of patients to use of Welltang, diabetes knowledge, and self-care behaviors. |
| File Format |
HTM / HTML |
| ISSN |
01688227 |
| Journal |
Diabetes Research and Clinical Practice |
| Volume Number |
116 |
| e-ISSN |
18728227 |
| Language |
English |
| Publisher |
Elsevier |
| Publisher Date |
2016-06-01 |
| Publisher Place |
Ireland |
| Access Restriction |
One Nation One Subscription (ONOS) |
| Subject Keyword |
Discipline Endocrinology |
| Content Type |
Text |
| Resource Type |
Article |
| Subject |
Endocrinology, Diabetes and Metabolism Internal Medicine Endocrinology |
